Company Overview

Agilent Technologies, Inc. is a global leader in analytical and clinical laboratory technologies, providing application-focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. Headquartered in Santa Clara, California, Agilent delivers insights and innovation that help customers bring great science to life. The company was incorporated in 1999 and has since established itself as a prominent player in the scientific instrumentation and solutions industry.

Business Segments

The company operates through three distinct business segments:

Life Sciences and Applied Markets

This segment offers a comprehensive suite of products including liquid and gas chromatography systems and components, mass spectrometry systems (LC-MS, GC-MS), inductively coupled plasma mass spectrometry (ICP-MS) instruments, atomic absorption and emission spectrometry instruments, microwave plasma-atomic emission spectrometry (MP-AES) instruments, and Raman spectroscopy. It also provides laboratory software, information management and analytics tools, laboratory automation and robotic systems, dissolution testing equipment, vacuum pumps, and measurement technologies. The segment further supplies GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument consumables.

Diagnostics and Genomics

This segment focuses on genomics, contract manufacturing and research and development services, pathology, companion diagnostics, reagent partnerships, and biomolecular analysis. It also provides cell analysis plate solutions tailored for various laboratory applications.

Agilent CrossLab

Agilent CrossLab is dedicated to providing services, consumables, and software solutions that support and optimize laboratory operations across the entire workflow, ensuring efficiency and reliability.

Financial Performance and Market Position

Agilent Technologies has demonstrated financial resilience with strong revenue generation and profitability. The company's strategic focus on innovation and market leadership in critical sectors like life sciences and diagnostics supports its financial performance.

Fiscal Year 2024 Performance Summary

For the fiscal year 2024, Agilent Technologies reported revenue of $6.51 billion, marking a slight decrease of -4.73% compared to the previous year's $6.83 billion. However, earnings showed an increase of 3.95%, reaching $1.29 billion.

Recent Quarterly Performance (Q3 FY2025)

The company showed significant recovery momentum in the third quarter ended July 31, 2025. Revenue reached $1.74 billion, exceeding previous guidance and representing a reported growth of 10.1% (6.1% core growth) compared to the third quarter of 2024.

Key Q3 FY2025 Metrics:

• Revenue: $1.74 billion (up 10.1% reported, 6.1% core)

• GAAP Net Income: $336 million, or $1.18 per share (vs. $282 million, $0.97 per share in Q3 FY2024)

• Non-GAAP Net Income: $390 million, or $1.37 per share (vs. $385 million, $1.32 per share in Q3 FY2024)

Key Financial Metrics

• FY2024 Revenue: $6.51 billion

• FY2024 Earnings: $1.29 billion

• Q4 FY2024 Revenue: $1.70 billion (up 0.8% reported, down 0.3% core)

• Q4 FY2024 GAAP Net Income: $351 million, or $1.22 per share

• Q4 FY2024 Non-GAAP Net Income: $418 million, or $1.46 per share

• Q3 FY2025 Revenue: $1.74 billion

• Q3 FY2025 GAAP Net Income: $336 million, or $1.18 per share

• Q3 FY2025 Non-GAAP Net Income: $390 million, or $1.37 per share

• Market Capitalization: (As of latest available data, e.g., ~$70 Billion)

• Employees: Approximately 18,000 worldwide

Forward Outlook

For the full fiscal year, Agilent revised its revenue outlook to a range of $6.91 billion to $6.93 billion, representing reported growth of 6.2% to 6.5% (4.3% to 4.6% core growth). Non-GAAP Earnings Per Share (EPS) is projected to be between $5.56 and $5.59.

Strategic Transformation and Growth Initiatives

"Our third-quarter performance, which marks our fifth consecutive quarter of sequential core-revenue acceleration, is a testament to the success of our Ignite Transformation and our laser-like focus on profitable growth and operational excellence," stated Agilent President and CEO Padraig McDonnell. The company is implementing a new organizational structure designed to enhance agility and customer centricity.

Key strategic initiatives include:

- Enhanced pricing strategies

- Digital improvements across operations

- Robust cost optimization programs

- A market-focused, customer-first approach

Market Position and Operations

Agilent Technologies markets its extensive portfolio of analytical instruments, software, services, and consumables through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce channels. The company serves a diverse global customer base across the pharmaceutical, biotechnology, academic research, government, environmental testing, and food safety laboratory sectors. Its comprehensive offerings position Agilent as a trusted partner for customers requiring precise measurement and analysis solutions.

Corporate Information

• Ticker Symbol: NYSE: A

• Headquarters: Santa Clara, California, USA

• Founded: 1999

• Website: www.agilent.com

Agilent maintains a commitment to shareholder value, evidenced by its consistent dividend policy, with a quarterly dividend of 24.8 cents per share of common stock. This approach balances shareholder returns with strategic investments in growth initiatives. Agilent's focus on innovation, customer-centric solutions, and operational excellence positions it well to capitalize on the growing demand for advanced analytical and measurement technologies across its core markets.